Privi Speciality Chemicals Schedules Board Meeting & Earnings Call for Q3FY26 Results
Privi Speciality Chemicals Limited has announced a comprehensive financial reporting schedule with a board meeting on February 09, 2026, to consider Q3FY26 unaudited financial results, followed by an earnings conference call on February 10, 2026, at 4:00 PM IST. The company has implemented trading window restrictions from January 01 to February 12, 2026, and will make call transcripts available on its website within five working days.
*this image is generated using AI for illustrative purposes only.
Privi Speciality Chemicals Limited has announced that its Board of Directors will convene on February 09, 2026, to review and approve the company's quarterly financial performance, followed by an earnings conference call on February 10, 2026. These meetings represent key milestones in the company's regular financial reporting cycle and stakeholder communication.
Board Meeting Details
The board meeting has been scheduled in compliance with SEBI regulations, specifically under Regulation 29(1)(a) and 29(1)(e) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will take place at the company's board room located at Privi House, A-71, TTC, Thane Belapur Road, Koparkhairne, Navi Mumbai, Maharashtra.
| Meeting Parameter: | Details |
|---|---|
| Date: | February 09, 2026 |
| Venue: | Privi House, Navi Mumbai |
| Format: | Physical meeting with video conferencing option |
| Purpose: | Approve Q3FY26 financial results |
Earnings Conference Call Schedule
Following the board meeting, the company has scheduled an earnings conference call on February 10, 2026, at 4:00 PM IST. The call will discuss operational and financial performance for the quarter and nine months ended December 31, 2025, providing stakeholders with comprehensive insights into the company's business performance.
| Call Details: | Information |
|---|---|
| Date: | February 10, 2026 |
| Time: | 4:00 PM IST |
| Format: | Conference call with Q&A session |
| Access: | Pre-registration required |
| Primary Numbers: | +91 22 6280 1309, +91 22 7115 8210 |
Financial Results Review
The primary agenda involves consideration and approval of unaudited standalone and consolidated financial results under Ind-AS for the quarter and nine months ended December 31, 2025. This quarterly review will provide stakeholders with insights into the company's operational and financial performance during the third quarter of fiscal year 2026.
Trading Window Restrictions
In accordance with insider trading regulations, the company has implemented trading window restrictions for designated persons and their immediate relatives. The trading window, which closed on January 01, 2026, will remain shut until the financial results are announced.
| Trading Window: | Timeline |
|---|---|
| Closure Date: | January 01, 2026 |
| Reopening Date: | February 12, 2026 |
| Applicable To: | Designated persons and immediate relatives |
Regulatory Compliance and Transparency
The announcements demonstrate the company's adherence to regulatory requirements under Regulation 30 of SEBI LODR Regulations and commitment to transparent financial reporting. The intimations have been communicated to both BSE Limited and National Stock Exchange of India Ltd, ensuring compliance with listing obligations. A transcript of the earnings conference call will be made available on the company's official website at www.privi.com within five working days post conclusion of the call.
Historical Stock Returns for Privi Speciality Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.48% | -2.82% | -2.99% | +14.31% | +31.14% | 0.0% |
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
